Loss of heterozygosity analysis of 13q and 14q in human malignant mesothelioma

Genes Chromosomes and Cancer

Volumn 28, Issue 3, 2000, Pages 337-341

  De Rienzo, Assunta ^a   Jhanwar, Suresh C ^b   Testa, Joseph R ^a  

^a FOX CHASE CANCER CENTER   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLELE; ARTICLE; CHROMOSOME 13Q; CHROMOSOME 14Q; CHROMOSOME LOSS; CYTOGENETICS; GENE INACTIVATION; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; MALIGNANT MESOTHELIOMA; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

ALLELES; CHROMOSOMES, HUMAN, PAIR 13; CHROMOSOMES, HUMAN, PAIR 14; HUMANS; KARYOTYPING; LOSS OF HETEROZYGOSITY; MESOTHELIOMA; PLEURAL NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0034130516     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/1098-2264(200007)28:3<337::AID-GCC12>3.0.CO;2-B     Document Type: Article

References (21)

1. Abujiang P, Mori TJ, Takahashi T, Tanaka F, Kasyu I, Hitomi S, Hiai H. 1998. Loss of heterozygosity (LOH) at 17q and 14q in human lung cancers. Oncogene 17:3029-3033.
2. Balsara BR, Bell DW, Sonoda G, De Rienzo A, du Manoir S, Jhanwar S, Testa JR. 1999. Comparative genomic hybridization and loss of heterozygosity analyses identify a common region of deletion at 15q11.1-15 in human malignant mesothelioma. Cancer Res 59:450-454.
3. Bell DW, Jhanwar SC, Testa JR. 1997. Multiple regions of allelic loss from chromosome arm 6q in malignant mesothelioma. Cancer Res 57:4057-4062.
4. Bianchi AB, Mitsunaga SI, Cheng JQ, Klein WM, Jhanwar SC, Seizinger B, Kley N, Klein-Szanto AJ, Testa JR. 1995. High frequency of inactivating mutations in the neurofibromatosis type 2 gene (NF2) in primary malignant mesotheliomas. Proc Natl Acad Sci USA 92:10854-10858.
5. Bjorkqvist AM, Tammilehto L, Anttila S, Mattson K, Knuutila S. 1997. Recurrent DNA copy number changes in 1q, 4q, 6q, 9p, 13q, 14q and 22q detected by comparative genomic hybridization in malignant mesothelioma. Br J Cancer 75:523-7.
6. Cheng JQ, Jhanwar SC, Klein WM., Bell DW, Lee WC, Altomare DA, Nobori T, Olopade OI, Buckler AJ, Testa JR. 1994. p16 alterations and deletion mapping of 9p21-p22 in malignant mesothelioma. Cancer Res 54:5547-5551.
7. Herbers J, Schullerus D, Muller H, Kenck C, Chudek J, Weimer J, Bugert P, Kovacs G. 1997. Significance of chromosome arm 14q loss in nonpapillary renal cell carcinomas. Genes Chromosomes Cancer 19:29-35.
8. Hyytinen ER, Frierson HF, Boyd JC, Chung LWK, Dong JT. 1999. Three distinct regions of allelic loss at 13q14, 13q21-22, and 13q33 in prostate cancer. Genes Chromosomes Cancer 25:108-114.
9. Kuroki T, Fujiwara Y, Nakamori S, Imaoka S, Kanematsu T, Nakamura Y. 1995. Evidence for the presence of two tumour-suppressor genes for hepatocellular carcinoma on chromosome 13q. Br J Cancer 72:383-385.
10. Lee DJ, Koch WM, Yoo G, Lango M, Reed A, Califano J, Brennan JA, Westra WH, Zahurak M, Sidransky D. 1997. Impact of chromosome 14q loss on survival in primary head and neck squamous cell carcinoma. Clin Cancer Res 3:501-505.
11. Lee WC, Balsara B, Liu Z, Suresh C, Jhanwar S, Testa JR. 1996. Loss of heterozygosity analysis defines a critical region in chromosome 1p22 commonly deleted in human malignant mesothelioma. Cancer Res 56:4297-4301.
12. Lu YY, Suresh C, Jhanwar S, Cheng JQ, Testa JR. 1994. Deletion mapping of the short arm of chromosome 3 in human malignant mesothelioma. Genes Chromosomes Cancer 9:76-80.
13. Menon AG, Rutter JL, von Sattel JP, Synder H, Murdoch C, Blumenfeld A, Martuza RL, von Deimling A, Gusella JF, Houseal TW. 1997. Frequent loss of chromosome 14 in atypical and malignant meningioma: identification of a putative 'tumor progression' locus. Oncogene 14:611-616.
14. Murthy SS, Testa JR. 1999. Asbestos, chromosomal deletions, and tumor suppressor gene alterations in human malignant mesothelioma. J Cell Physiol 180:150-157.
15. Mutirangura A, Pornthanakasem W, Sriuranpong V, Supiyaphun P, Voravud N. 1998. Loss of heterozygosity on chromosome 14 in nasopharyngeal carcinoma. Int J Cancer 78:153-156.
16. Sekido Y, Pass HI, Bader S, Mew DJ., Christman MF, Gazdar AF, Minna JD. 1995. Neurofibromatosis type 2 (NF2) gene is somatically mutated in mesothelioma but not in lung cancer. Cancer Res 55:1227-1231.
17. Shivapurkar N, Virmani AK, Wistuba II, Milchgrub S, Mackay B, Minna JD, Gazdar AF. 1999. Deletions of chromosome 4 at multiple sites are frequent in malignant mesothelioma and small cell lung carcinoma. Clin Cancer Res 5:17-23.
18. Taguchi T, Jhanwar SC, Siegfried JM, Keller SM, Testa JR. 1993. Recurrent deletions of specific chromosomal sites in 1p, 3p, 6q, and 9p in human malignant mesothelioma. Cancer Res 53:4349-4355.
19. Tamura K, Zhang X, Murakami Y, Hirohashi S, Xu HJ, Hu SX, Benedict WF, Sekiya T. 1997. Deletion of three distinct regions on chromosome 13q in human non-small-cell lung cancer. Int J Cancer 74:45-49.
20. Van Der Meeren A, Seddon MB, Kispert J, Harris CC, Gerwin BI. 1993. Lack of expression of the retinoblastoma gene is not frequently involved in the genesis of human mesothelioma. Eur Respir Rev 3:177-179.
21. Weinberg R. 1991. Tumor suppressor genes. Science 254:1138-1146.